The following are brief sketches that describe the professional training and experience of the Work Group members, particularly as they relate to the DOQI Nutrition Guidelines, as well as their principle business affiliations. All Work Group members completed a disclosure statement and certified that any potential conflict of interest would not influence their judgement or actions concerning the guidelines.
Suhail Ahmad, BSc, MB, BS, MD, is Associate Professor of Medicine and Medical Director for Dialysis and Apheresis at the University of Washington, Seattle, and Medical Director at the Scribner Kidney Center, Seattle. He completed his Fellowship at the University of Washington under Dr Belding Scribner and continued Dr Scribner's research after his retirement. Dr Ahmad has served on the Editorial Board of several nephrology journals and has published over 115 papers, including abstracts, book chapters, and one book on dialysis. He holds three patents related to dialysis technology. He is the current Chair of the Medical Review Board and Member of the Board of Directors for ESRD Network 16, current Chair of the Executive Committee of the Medical Staff of Northwest Kidney Center, Seattle, and past Member of the Executive Board of the ESRD Forum of Networks. Dr Ahmad is the recipient of the Excellent Teaching Award at the University of Washington and is listed in Best Doctors. He has received research grants and/or gives lectures for the following companies: Advanced Renal Technologies, Hoechst Marion Roussel, Novartis, Sigma-Tau Pharmaceuticals, Inc, Astra Zeneca, and Searle.
Jerrilynn D. Burrowes, MS, RD, CDN, is Research Coordinator for the Division of Nephrology and Hypertension at Beth Israel Medical Center in New York City. Ms Burrowes has has worked to improve the nutritional status and outcome of patients with ESRD for over a decade and has published several papers on these topics. Ms Burrowes is a doctoral candidate in the Department of Nutrition and Food Studies at New York University. She has also served on the Executive Committee for the National Kidney Foundation Council on Renal Nutrition and the Council on Renal Nutrition of Greater New York. Ms Burrowes is currently Chair of the CRN Program for the NKF Clinical Nephrology Meetings 2000. She is Study Coordinator at Beth Israel Medical Center for the NIH-sponsored Hemodialysis (HEMO) Study to evaluate the potential values of different dialysis doses and high versus low flux dialyzer membranes for maintenance hemodialysis patients. Ms Burrowes is an active member of the Nutrition Subcommittee that developed the nutrition component for this study.
Glenn M. Chertow, MD, MPH, is Assistant Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and Director of Clinical Services in the Divisions of Nephrology at Moffitt-Long Hospitals and UCSF-Mt. Zion Medical Center. He is Medical Director of the Hemodialysis and Peritoneal Dialysis programs at both clinical sites. In addition to ABIM-certification in Internal Medicine and Nephrology, he has been designated a Certified Nutrition Support Physician (CNSP) by the American Society of Parenteral and Enteral Nutrition (ASPEN) and practices nutrition support in the critical care setting. Dr Chertow's research interests are focused on the epidemiology of acute and chronic renal failure, with a special interest in nutrition and renal diseases. He has written numerous papers on end-stage renal disease, dialysis therapy, and nutritional status. He is Associate Editor of the Journal of Renal Nutrition. He currently serves on the Board of Directors of the TransPacific Renal Network (ESRD Network #17), the Scientific Program Committee of the American Kidney Fund, and the Program Committee for NKF Clinical Nephrology 2000. Dr Chertow has served as a consultant for Amgen, Inc, and GelTex Pharmaceuticals, Inc, and has received research funding from GelTex Pharmaceuticals, Inc, and Genzyme, Inc.
David B. Cockram, MS, RD, LD, is a Research Scientist in Medical and Regulatory Affairs at the Ross Products Division of Abbott Laboratories. He has been actively conducting clinical trials in the areas of nutritional assessment and nutrition in renal disease for the past 12 years. He has written more than 75 scientific publications and presentations. Mr Cockram is currently a PhD Candidate at Ohio State University and a member of the American Dietetic Association, the National Kidney Foundation Council on Renal Nutrition, the American Society for Nutritional Sciences, and the American Society of Clinical Nutrition.
Denis Fouque, MD, PhD, is Professor of Nephrology at the University Claude Bernard at Lyon, France, and Director of the Clinical Renal Unit at Hôpital Edouard Herriot. He is also the co-ordinating Editor of the Renal Group of the Cochrane Collaboration, based in Lyon. In addition to 10 years of clinical research on metabolism and nutrition in chronic renal failure, Dr Fouque has performed a number of meta-analyses and systematic reviews in the renal field, including the effects of low-protein diets on the role of progressive to end-stage renal failure in patients with chronic renal disease and the use of carnitine in hemodialysis patients. He has published more than 50 papers, including book chapters, on nutrition and renal diseases. He contributed to the French INSERM statement on malnutrition published in 1999 and to the European Nutritional Guidelines in Renal Disease (to be released). Dr Fouque is Associate Editor of the Journal of Renal Nutrition. Dr Fouque has received an Extramural grant from Baxter Healthcare, Inc, and has served as a consultant for them.
Charles J. Foulks, MD, FACP, FACN, is Professor of Medicine at Texas A&M University Health Sciences Center and College of Medicine and Director of the Division of Nephrology and Hypertension at Scott and White Hospital and Clinic in Temple, Texas. He served as Chairman of the Department of Internal Medicine at the University of North Dakota from 1996 to 1998. He has practiced clinical nephrology for over 20 years and has published numerous papers in the field of nutrition, particularly renal nutrition, with an emphasis on nutrition support and intradialytic parenteral nutrition. He was a member of the original HCFA Expert Panel on Quality in Dialysis. He has served on the National Kidney Foundation task forces on the initiation and withdrawal of dialysis, as well as the Expert Panel on Nutrition, which was a precursor to the DOQI Nutrition Work Group. He served as a member of the Medical Review Board for ESRD Network 14 of Texas from 1992 to 1996. Dr Foulks is also a member of the editorial board of the Journal of Renal Nutrition and is an associate editor of Nutrition in Clinical Practice. He has been a speaker for NMC and NMC Home Care and is currently on the Scientific Advisory Board for R&D Labs.
Joel D. Kopple, MD, FACP, (Work Group Chair) is Professor of Medicine and Public Health at the UCLA Schools of Medicine and Public Health and Chief of the Division of Nephrology and Hypertension at Harbor-UCLA Medical Center. Dr Kopple has published over 320 papers primarily in the fields of nutrition and metabolism, particularly as they relate to renal disease or renal failure. Dr Kopple is past President of the American Society for Parenteral and Enteral Nutrition, the International Society for Renal Nutrition and Metabolism and the Council of American Kidney Societies and is a past Director of the American Board of Nutrition. He is currently President of the National Kidney Foundation. Dr Kopple is a coeditor of 10 proceedings of meetings or symposia on general nutrition or nutrition and renal disease and is the coeditor of the book entitled Nutritional Management of Renal Disease. He has served as a reviewer or member of the editorial review boards of many journals. Dr Kopple has served as a consultant for many pharmaceutical or other health care companies, including Abbott Laboratories, Baxter Healthcare, Sigma-Tau Pharmaceuticals, Inc, and Total Renal Care, Inc.
Bradley Maroni, MD, is a Product Development Team Leader at Amgen, Inc. Prior to assuming that position he was a member of the Nephrology faculty at Emory University in Atlanta, Georgia, for 10 years. During that tenure he was active in NIH sponsored research investigating the impact of renal failure on protein metabolism and the dietary requirements of the patient with progressive chronic renal failure. He has published extensively in the field of nutrition and renal disease. Dr Maroni also served as a Co-Investigator for the NIH-sponsored Modification of Diet in Renal Disease (MDRD) Study and Principal Investigator at Emory University for the Morbidity and Mortality in Hemodialysis (HEMO) Study. Dr Maroni serves on several journal editorial boards and is active in many renal societies.
Linda W. Moore, RD, is currently Director of Scientific Publications for SangStat Medical Corporation. She has worked in dialysis and transplantation for many years at the University of Tennessee-Memphis where she focused on clinical outcomes in developing research protocols and patient care protocols. Ms Moore has published over 50 articles on renal nutrition and on transplantation for improving patient outcomes. Ms Moore is currently the Chair of the Council on Renal Nutrition for the National Kidney Foundation, serves as a work group member of the ESRD Core Indicators for the Health Care Finance Administration, and was a member of the NKF-DOQI Peritoneal Dialysis Adequacy Work Group.
Marsha Wolfson, MD, FACP, is Medical Director of the Renal Division at Baxter HealthCare. Prior to joining Baxter, she was Professor of Medicine at Oregon Health Sciences University and Chief of the Nephrology Section at the Portland VA Medical Center. She currently holds the title of Clinical Professor of Medicine in the Division of Nephrology and Hypertension at Oregon Health Sciences University. Her research interests have primarily focused on nutrition and metabolism in renal disease and she has numerous publications and book chapters in this area.
James C.M. Chan, MD, is Professor of Pediatrics and Professor of Biochemistry and Molecular Biophysics at Virginia Commonwealth University in Richmond. He has served on the faculties of the University of Southern California Children's Hospital of Los Angeles and George Washington University's Children's National Medical Center in Washington, DC. He has spent two sabbaticals at the National Institutes of Health (NIH). From 1983 to 1993, he led a consortium of 25 universities, funded by the NIH, to study the growth failure of children with renal diseases. In addition, Dr Chan has been funded since 1996 by the NIH to study progressive IgA nephropathy. Finally, he has been the director of a pediatric nephrology training program funded by the NIH since 1988 and coedited two textbooks: Kidney Electrolyte Disorders (Churchill-Livingstone) and Phosphate in Pediatric Health and Disease (CRC Press).
Richard N. Fine, MD, is Professor and Chairman of the Department of Pediatrics at the State University of New York at Stonybrook. Dr Fine has been involved in the clinical management of children with end-stage renal disease (ESRD) for more than 3 decades. He was instrumental in demonstrating that the duel therapeutic modalities of dialysis and renal transplantation were applicable to the treatment of children with ESRD. Dr Fine's research activities include the use of recombinant human growth hormone for children with growth retardation due to chronic renal insufficiency, dialysis or transplantation, and the utilization of peritoneal dialysis as an optimal therapeutic modality for infants, children, and adolescents. Dr Fine is past President of the American Society of Pediatric Nephrology and past member of the Council of the International Society for Peritoneal Dialysis, International Pediatric Nephrology Association, and International Transplant Society. He is currently a member of the Council of the American Society of Transplantation and the International Pediatric Transplantation Society. Dr Fine is on the Board of Directors for the Genentech Foundation.
Craig B. Langman, MD, is a Tenured Professor of Pediatrics at Northwestern University Medical School and Head of Nephrology and Mineral Metabolism and Director of Dialysis at Children's Memorial Medical Center in Chicago. Dr Langman's research has focused on the anatomical, biochemical and clinical expression of inherited or acquired disorders of calcium, phosphorus and vitamin D metabolism in infants, children, and adolescents. He has pioneered the use of noninvasive testing in children to assess bone cell function. Dr Langman has published more than 125 articles in his discipline and currently serves on the Editorial Advisory Boards of Advances in Renal Replacement Therapy and Pediatric Endocrinology. He previously served on the Editorial Advisory Board of Pediatric Nephrology. Dr Langman has served as President of the American Board of Pediatrics subboard of Pediatric Nephrology, the American Society of Pediatric Nephrology, and the Council of American Kidney Societies. He has served on the Scientific Advisory Board, Public Policy, and the Executive Committee of the Council of Pediatric Urology and Nephrology Committees, among others, of the National Kidney Foundation. He has also served on the Growth Advisory Board of the North American Pediatric Renal Transplant Cooperative Study. Dr Langman serves on the Academic Advisory Board of Total Renal Care, Inc. He has served as a consultant for many pharmaceutical laboratories, health care companies, and health care related Foundations, including Merck USA, Roche Pharmaceuticals, Abbott Laboratories, and the Oxalosis and Hyperoxaluria Foundation.
Bruce Morgenstern, MD, is an Associate Professor of Pediatrics at the Mayo Clinic and Mayo Medical School in Rochester, MN, and Consultant in Pediatric Nephrology. Dr Morgenstern has a longstanding interest in clinical and basic research in peritoneal dialysis, as well as the evaluation and management of children with hypertension. He is currently the Principal Investigator of a multicenter study of peritoneal adequacy in children, involving the Pediatric Peritoneal Dialysis Study Consortium institutions. This study is partly funded by Baxter Healthcare.
Pauline Nelson, RD, is the Pediatric Renal Dietitian at the UCLA Center for the Health Sciences, working with children in the inpatient and outpatient settings on all modalities of ESRD care. She has participated in many clinical research studies related to growth and nutrition, especially in the areas of recombinant human growth hormone and peritoneal dialysis. Ms Nelson has written numerous professional and lay papers on various aspects of nutrition in ESRD, with a particular emphasis on practical approaches to the delivery of nutrients. She has been active in the American Dietetic Association and the Council on Renal Nutrition of the National Kidney Foundation on local and national levels.
Isidro B. Salusky, MD, FAAP, is Professor of Pediatrics at UCLA School of Medicine, Program Director of the UCLA General Clinic Research Center, and Director of the Pediatric Dialysis Program. He has a long-standing interest in the fields of growth and nutrition in children with renal failure that has ranged from experimental models to patients treated with maintenance dialysis. Dr Salusky has done extensive work to characterize the syndromes of renal osteodystrophy in children with chronic renal failure undergoing regular dialysis and postrenal transplantation. Dr Salusky has published more than 150 papers and is very active in many professional societies. During the course of these studies, Dr Salusky has been successful in obtaining funding from the National Institutes of Health, as well as from other profit and nonprofit organizations. He is a consultant for Genzyme, Inc, Bone Care International, and Abbott Laboratories.
Bradley A. Warady, MD, is Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and Chief of Nephrology and Director of Dialysis and Transplantation at the Children's Mercy Hospital. Dr Warady's clinical and research focus is end-stage renal disease with particular emphasis on peritoneal dialysis. He established the Pediatric Peritoneal Dialysis Study Consortium and currently codirects research projects on a number of topics, including growth hormone usage in pediatric dialysis patients, peritoneal dialysis adequacy in children, and intravenous iron therapy in pediatric patients receiving hemodialysis. He coedited the book CAPD/CCPD in Children and has published more than 150 papers. Dr Warady currently serves on the executive committees of the American Society of Pediatric Nephrology, the Pediatric Nephrology and Urology Committee of the National Kidney Foundation, and the Nephrology section of the American Academy of Pediatrics. Dr Warady is a member of the Editorial Board for Advances of Renal Replacement Therapy, and he is also a member of the NKF B DOQI Peritoneal Dialysis Adequacy Work Group. Dr Warady has had research funded by Baxter Health Care and Schein Pharmaceuticals.